Outcome measures: Linking science and ethics in clinical research

Current Opinion in Allergy and Clinical Immunology

Volumn 6, Issue 3, 2006, Pages 139-143

  O'Lonergan, Theresa A ^a   Milgrom, Henry ^b  

^a Children's Hospital Colorado   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL RESEARCH; CONTENT VALIDITY; DEONTOLOGY; DRUG EFFICACY; FIBEROPTIC BRONCHOSCOPY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; LONG TERM CARE; MEDICAL ETHICS; NULL HYPOTHESIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RESEARCH ETHICS; REVIEW; RISK BENEFIT ANALYSIS; SCIENTIST; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; CLINICAL TRIAL; EDITORIAL; ETHICS; QUALITY OF LIFE; SAFETY;

ASTHMA; CLINICAL TRIALS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; SAFETY;

EID: 33745578647     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/01.all.0000225148.06909.61     Document Type: Review

References (27)

1. Kant I. Foundations of the metaphysics of morals. 2nd ed. White Beck L, editor. New York: Macmillan/Library of Liberal Arts; 1990.
2. Mill J. Utilitarianism. New York: The Library of Liberal Arts, Bobbs-Merrill; 1957.
3. Harris J. Scientific research is a moral duty. J Med Ethics 2005; 31:242-248.
4. Emanuel E, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000; 283:2701-2711.
5. Weithorn L. The competency of children and adolescents to make informed treatment decisions. Child Dev 1982; 53:1589-1598.
6. Weithorn L. Children's capacities to decide about participation in research. IRB 1983; 5:1-5.
7. National Institutes of Health, National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program, Expert Panel Report 2: Guidelines for the diagnosis and management of asthma; 1997. Publ. No. 97-4051.
8. National Institutes of Health, National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program, Expert Panel Report: Guidelines for the diagnosis and management of asthma update on selected topics: 2002. J Allergy Clin Immunol 2002; 110:s141-s219.
9. British Thoracic Society. The British guidelines on asthma management: 1995 review and position statement. Thorax 1997; 52:S1-S21.
10. GINA. 2002 original workshop report. Global strategy for asthma management and prevention: evidence-based guidelines for asthma management and prevention, with citations from the scientific literature. NIH Publication No. 02-3659. http://www.ginasthma.com/Guidelineitem.asp?l1=2&l2=1&intId=82. [Accessed 4 January 2006]
11. GINA. Workshop report. Global strategy for asthma management and prevention: updated 2005. http://www.ginasthma.com/GuidelinesResources. asp?l1=2&l2=0. [Accessed 4 January 2006]
12. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88:373-381.
13. Zeiger R. Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP). J Allergy Clin Immunol 1999; 103:376-387.
14. Haahtela T, Jarvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Eng J Med 1994; 331:700-705.
15. Jarjour NN, Peters SP, Djukanovic R, Calhoun WJ. Investigative use of bronchoscopy in asthma. Am J Respir Crit Care Med 1998; 157 (Pt 1): 692-697.
16. Sahn S, Scoggin C. Fiberoptic bronchoscopy in bronchial asthma: a word of caution. Chest 1976; 69:39-42.
17. Chanez P, Bourdin A, Vachier I, et al. Effects of inhaled corticosteroids on pathology in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1:184-190.
18. Balzar S, Wenzel S, Chu H. Transbronchial biopsy as a tool to evaluate small airways in asthma. Eur Respir J 2002; 20:254-259.
19. Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med 2005; 172:149-160.
20. Ericka Grimes v. Kennedy Kreiger Institute, Inc., Maryland Court of Appeals; 2001.
21. WMA. Declaration of Helsinki, 1964: revised in 1975, 1982. 1989, 1996. 2000. Ferney-Voltaire, France: World Medical Association; 1964.
22. Ellenberg S, Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: Practical issues and specific cases. Ann Intern Med 2000; 133:464-470.
23. Temple R, Ellenberg S. Placebo-controlled trials and active-control trials in evaluation of new treatments. Part 1: Ethical and scientific issues. Ann Intern Med 2000; 133:455-463.
24. Luna F. Is 'best proven' a useless criterion? Bioethics 2001; 15:273-288.
25. National Institutes of Health Conference. Considering usual care in the design of clinical trials: scientific and ethical issues; 14-15 November 2005; Washington, DC.
26. Whitehead A. The function of reason. Boston: Beacon Press; 1971.
27. Highet G. Man's unconquerable mind. New York: Columbia University Press; 1953.